The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2014

Filed:

Sep. 09, 2013
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Carol Bachand, Candiac, CA;

Makonen Belema, North Haven, CT (US);

Daniel H. Deon, Montreal, CA;

Andrew C. Good, Wallingford, CT (US);

Jason Goodrich, Wallingford, CT (US);

Clint A. James, Candiac, CA;

Rico Lavoie, Candiac, CA;

Omar D. Lopez, Wallingford, CT (US);

Alain Martel, Delson, CA;

Nicholas A. Meanwell, East Hampton, CT (US);

Van N. Nguyen, Middletown, CT (US);

Jeffrey Lee Romine, Meriden, CT (US);

Edward H. Ruediger, Greenfield Park, CA;

Lawrence B. Snyder, Killingworth, CT (US);

Denis R. St. Laurent, Newington, CT (US);

Fukang Yang, Madison, CT (US);

David R. Langley, Meriden, CT (US);

Gan Wang, Cheshire, CT (US);

Lawrence G. Hamann, North Grafton, MA (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 417/14 (2006.01); A61K 31/506 (2006.01); A61K 31/4178 (2006.01); A61K 31/427 (2006.01); A61K 31/13 (2006.01); A61K 31/7105 (2006.01); A61K 31/4745 (2006.01); A61K 31/7056 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 38/208 (2013.01); A61K 38/204 (2013.01); A61K 31/4745 (2013.01); A61K 31/7105 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 417/14 (2013.01); A61K 38/2013 (2013.01); A61K 31/427 (2013.01); A61K 31/7056 (2013.01); A61K 31/13 (2013.01); A61K 38/21 (2013.01); A61K 38/212 (2013.01); A61K 31/4178 (2013.01); C07D 405/14 (2013.01);
Abstract

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.


Find Patent Forward Citations

Loading…